Live
- Sensex, Nifty fall more than 1 pc as global risks weigh on market sentiment
- Hippocratic oath reduced to hypocrisy by noble men
- About 145 students secure jobs
- Tragic Murder-Suicide in Begum Bazaar: Man Kills Wife and Son Before Ending His Own Life
- Double valve replacement surgery performed successfully in Kurnool GGH
- RBI gets bomb threat in 'Russian' language, 2nd time in a month
- Atul Subhash suicide case: Wife absconds, K'taka Police arrest her mother, brother
- Garena Free Fire MAX Redeem Codes for December 13, 2024: Exclusive Rewards Await!
- Call to include Veera Saivas in OBC category
- December 2024: 5G Smartphones Under Rs 25,000 - Nothing Phone (2a) and More
Five more Covid vaccines in pipeline
Five more Covid vaccines in pipeline
Johnson & Johnson, Sputnik V expected by Oct
The Centre is gearing to scale up the Covid-19 vaccine production as more and more States flag shortage of vaccine doses. It is expected that by the end of the third quarter of 2021, India will get five additional vaccine manufacturers apart from current manufactures Covishield and Covaxin.
Around 20 Covid-19 vaccines are in various clinical and pre-clinical stages and will add a boost to India's vaccine production. As per top government sources, the new strategy is to manufacture additional vaccine doses.
"These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's intranasal vaccine," a source was quoted as saying. Sputnik V vaccine is expected to get the Emergency Use Approval (EUA) within the next ten days.
